Antimicrobial Agents Practice Questions

Q: Which among the following antimicrobials exhibits a long post-antibiotic effect?

Quinolones. **Explanation:** The **Post-Antibiotic Effect (PAE)** refers to the persistent suppression of bacterial growth even after the concentration of the antibiotic falls below the Minimum Inhibitory Concentration (MIC) at the site of infection. **Why Quinolones are Correct:** Fluoroquinolones (e.g., Ciprofloxacin, Levofloxacin) exhibit a **significant and long PAE** against both Gram-negative and Gram-positive bacteria. This occurs because they cause irreversible damage to bacterial DNA by inhibiting DNA gyrase and Topoisomerase IV. Even after the drug is cleared, the bacteria require considerable time to synthesize new enzymes and repair DNA before growth can resume. This property supports their **concentration-dependent killing** profile. **Analysis of Incorrect Options:** * **Beta-lactams (e.g., Penicillins, Cephalosporins):** These generally exhibit a very short or **negligible PAE** against Gram-negative bacilli. Their efficacy is **time-dependent**, meaning the concentration must remain above the MIC for as long as possible. (Exception: Carbapenems show some PAE against *Pseudomonas*). * **Macrolides (e.g., Erythromycin):** While they show some PAE, it is generally less consistent and shorter than that of Quinolones or Aminoglycosides in clinical practice. * **Oxazolidinones (e.g., Linezolid):** These exhibit a modest PAE, but it is not the defining pharmacokinetic characteristic compared to the robust PAE of Quinolones. **NEET-PG High-Yield Pearls:** 1. **Aminoglycosides** also exhibit a very long PAE, which justifies their **once-daily dosing** regimen. 2. **Concentration-dependent killers** (Quinolones, Aminoglycosides) typically have long PAEs. 3. **Time-dependent killers** (Beta-lactams) typically have short or no PAEs. 4. PAE allows for wider dosing intervals, reducing systemic toxicity while maintaining efficacy.

Q: Which of the following adverse effects of Penicillin is dose-related?

Encephalopathy. **Explanation:** The adverse effects of Penicillins are broadly categorized into **Hypersensitivity reactions** (non-dose-related/idiosyncratic) and **Direct toxicities** (dose-related). **1. Why Encephalopathy is correct:** Penicillin-induced neurotoxicity, manifesting as **encephalopathy** or seizures, is a **dose-dependent** adverse effect. It occurs due to the GABA-antagonistic activity of the beta-lactam ring. This typically happens when very high doses are administered intravenously or in patients with **renal impairment** where the drug accumulates, leading to high cerebrospinal fluid (CSF) concentrations. **2. Why other options are incorrect:** * **Skin rash (A), Interstitial Nephritis (B), and Drug fever (C):** These are all manifestations of **Hypersensitivity (Allergic) reactions**. * **Skin rashes** (urticarial or maculopapular) are the most common allergic manifestations. * **Interstitial Nephritis** is a Type IV hypersensitivity reaction (classically associated with Methicillin). * **Drug fever** is an immune-mediated response. These reactions are idiosyncratic, meaning they can occur even with a very small dose in a sensitized individual and are not proportional to the quantity of the drug administered. **High-Yield Clinical Pearls for NEET-PG:** * **Jarisch-Herxheimer Reaction:** A unique non-dose-related reaction seen during the treatment of Syphilis with Penicillin due to the release of endotoxins from dying spirochetes. * **Most common cause of Anaphylaxis:** Penicillin remains the most common drug trigger for Type I hypersensitivity. * **Renal Adjustment:** Since most penicillins are excreted by the kidney, doses must be adjusted in renal failure to prevent dose-related toxicities like encephalopathy. (Exception: **Nafcillin** is primarily excreted via bile).

Q: The dose of which antibiotic need not be altered in renal failure?

Erythromycin. **Explanation:** The primary factor determining whether a drug requires dose adjustment in renal failure is its **route of elimination**. Drugs that are primarily excreted unchanged by the kidneys require dose reduction to prevent toxicity, whereas drugs metabolized by the liver or excreted via bile do not. **Why Erythromycin is correct:** Erythromycin is a macrolide antibiotic that is primarily metabolized by the **liver** and excreted mainly in the **bile**. Only a small fraction (approx. 2–5%) is excreted unchanged in the urine. Therefore, its pharmacokinetics are not significantly altered by declining renal function, making it safe to use at standard doses in patients with renal failure. **Why the other options are incorrect:** * **Vancomycin:** It is almost exclusively excreted by glomerular filtration. In renal failure, it can accumulate rapidly, leading to nephrotoxicity and ototoxicity. Dosing must be adjusted based on creatinine clearance and serum drug monitoring. * **Ethambutol:** About 80% of the drug is excreted unchanged in the urine. Accumulation in renal failure can lead to **optic neuritis**, a classic side effect. * **Ciprofloxacin:** This fluoroquinolone is eliminated via both renal (tubular secretion and filtration) and hepatic routes. In patients with a GFR < 30 ml/min, the dose must be reduced. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for antibiotics safe in renal failure:** "**D**on't **C**hange **M**edicine **E**verytime" (**D**oxycycline, **C**eftriaxone/Chloramphenicol, **M**acrolides/Metronidazole, **E**rythromycin). * **Doxycycline** is the tetracycline of choice in renal failure because it is excreted via the gut. * **Ceftriaxone** is primarily eliminated via biliary excretion, requiring no adjustment unless there is concurrent hepatic impairment.

Q: Which antifungal agent is also used as a chemotherapeutic agent for cancer?

Flucytosine. **Explanation:** **Flucytosine (5-Fluorocytosine)** is the correct answer because it is a pyrimidine antimetabolite. Its mechanism of action involves being taken up by fungal cells via the enzyme **cytosine permease** and subsequently converted into **5-fluorouracil (5-FU)** by **cytosine deaminase**. 5-FU is a potent chemotherapeutic agent used in treating various cancers (e.g., colorectal and breast cancer). In fungal cells, 5-FU inhibits thymidylate synthase, disrupting DNA synthesis. While humans lack cytosine deaminase (limiting toxicity), 5-FU itself is a cornerstone of oncology. **Analysis of Incorrect Options:** * **Nystatin:** A polyene antifungal used topically for Candidiasis. It is too toxic for systemic use and has no role in chemotherapy. * **Voriconazole:** A second-generation triazole that inhibits ergosterol synthesis. It is the drug of choice for Invasive Aspergillosis but lacks antineoplastic properties. * **Terbinafine:** An allylamine that inhibits squalene epoxidase. It is primarily used for dermatophytoses (onychomycosis) and is not used in cancer treatment. **High-Yield Clinical Pearls for NEET-PG:** * **Synergy:** Flucytosine is rarely used alone due to rapid resistance; it is most commonly combined with **Amphotericin B** for Cryptococcal meningitis. * **Adverse Effects:** The most significant side effect is **bone marrow suppression** (anemia, leukopenia, thrombocytopenia), which mimics the toxicity of traditional chemotherapy. * **Mechanism Link:** Remember: Flucytosine $\rightarrow$ 5-FU $\rightarrow$ Inhibition of Thymidylate Synthase (Thymineless death).

Q: Which anti-tubercular drug is not typically given to children under 6 years of age?

Ethambutol. **Explanation:** **Ethambutol** is the correct answer because its most significant dose-dependent side effect is **retrobulbar neuritis**, which manifests as decreased visual acuity and a loss of red-green color discrimination [1]. In children under 6 years of age, reliable monitoring of visual acuity and color vision is clinically challenging due to their inability to cooperate with formal ophthalmological testing (like Snellen charts or Ishihara plates) [1]. Therefore, to prevent irreversible vision loss that might go undetected, it is traditionally avoided in young children unless absolutely necessary [1]. **Analysis of Incorrect Options:** * **Isoniazid (B):** A cornerstone of pediatric TB treatment. While it can cause peripheral neuropathy (prevented by Pyridoxine), it is safe and routinely used in all age groups. * **Streptomycin (C):** An aminoglycoside that can cause ototoxicity and nephrotoxicity. While it requires monitoring, it is not contraindicated based on age alone, though it is less preferred due to its injectable route. * **Rifampicin (D):** A primary bactericidal drug used in pediatric regimens. Its main side effect is orange discoloration of secretions and hepatotoxicity, but it is safe for infants and children. **NEET-PG High-Yield Pearls:** * **Mechanism of Action:** Ethambutol inhibits **Arabinosyl transferase**, preventing cell wall synthesis. * **Visual Monitoring:** Patients on Ethambutol should have baseline and monthly visual acuity and color vision checks [1]. * **Hyperuricemia:** Ethambutol decreases the excretion of uric acid and can precipitate **Gout** (similar to Pyrazinamide). * **Bacteriostatic:** Among the first-line ATT (HRZE), Ethambutol is the only drug that is primarily bacteriostatic.

Q: In a patient with culture-positive enterococcal endocarditis who has failed to respond to vancomycin due to resistance, what is the most likely effective treatment?

Linezolid. **Explanation:** The clinical scenario describes a case of **Vancomycin-Resistant Enterococci (VRE)** endocarditis. Enterococci are naturally resilient organisms, and the emergence of VRE (particularly *E. faecium*) poses a significant therapeutic challenge. **Why Linezolid is correct:** Linezolid is an oxazolidinone antibiotic that inhibits protein synthesis by binding to the **23S ribosomal RNA of the 50S subunit**, preventing the formation of the 70S initiation complex. It is a first-line agent for VRE infections. Its unique mechanism of action ensures there is no cross-resistance with other protein synthesis inhibitors. Other alternatives for VRE include Daptomycin and Quinupristin-Dalfopristin. **Why the other options are incorrect:** * **Clarithromycin (Macrolide):** Enterococci exhibit inherent resistance to macrolides; they are never used as monotherapy for endocarditis. * **Minocycline (Tetracycline):** While it has a broad spectrum, it is bacteriostatic and lacks sufficient clinical efficacy against systemic VRE endocarditis. * **Ticarcillin (Antipseudomonal Penicillin):** Enterococci are generally resistant to ticarcillin. While some enterococci are sensitive to Ampicillin, VRE strains are almost always resistant to all beta-lactams. **High-Yield NEET-PG Pearls:** * **Linezolid Side Effects:** Long-term use (>2 weeks) can lead to **bone marrow suppression** (thrombocytopenia is most common) and **optic/peripheral neuropathy**. * **Drug Interaction:** Linezolid is a weak non-selective **MAO inhibitor**. It can precipitate **Serotonin Syndrome** if co-administered with SSRIs. * **VRE Mechanism:** Resistance to Vancomycin occurs due to the alteration of the D-Ala-D-Ala peptidoglycan terminus to **D-Ala-D-Lac** or D-Ala-D-Ser.

Q: A 30-year-old female with PCOD, on treatment, presented with complaints of hirsutism. She was given a topical cream that inhibits the ornithine decarboxylase enzyme. Which of the following parasitic infections can be managed with this drug?

West African trypanosomiasis. ### Explanation **1. Understanding the Drug (Eflornithine)** The drug described is **Eflornithine**. In dermatology, it is used topically to treat female hirsutism because it inhibits **ornithine decarboxylase (ODC)**, an enzyme essential for polyamine synthesis required for hair follicle growth. Systemically, Eflornithine is a potent antiprotozoal agent. **2. Why West African Trypanosomiasis is Correct** Eflornithine is the drug of choice for the second stage (meningoencephalitic stage) of **West African Trypanosomiasis** caused by *Trypanosoma brucei gambiense*. It acts as a "suicide inhibitor" of ODC in the parasite. Since *T. b. gambiense* has a slow turnover rate for ODC, the drug effectively halts its replication. **3. Why Other Options are Incorrect** * **East African Trypanosomiasis (*T. b. rhodesiense*):** Eflornithine is **ineffective** here because this subspecies has a rapid turnover of the ODC enzyme, allowing it to bypass the drug's effects. Suramin or Melarsoprol are used instead. * **South American Trypanosomiasis (Chagas Disease):** Caused by *Trypanosoma cruzi*. The treatment of choice is Benznidazole or Nifurtimox. * **Visceral Leishmaniasis (Kala-azar):** Treated with Liposomal Amphotericin B (drug of choice), Miltefosine, or Paromomycin. **Clinical Pearls for NEET-PG:** * **Eflornithine** is nicknamed "the resurrection drug" because of its dramatic effect on patients in comatose states of African Sleeping Sickness. * **Route of Administration:** Topical for hirsutism; Intravenous for Sleeping Sickness. * **Mechanism:** Irreversible inhibition of Ornithine Decarboxylase. * **Side effects:** Anemia, leukopenia, and seizures (when given systemically).

Q: A diabetic patient presents with fungal infection of sinuses and peri-orbital region with significant visual impairment. What is the best drug for treatment of this patient?

Amphotericin B. ### Explanation **Correct Option: A (Amphotericin B)** The clinical presentation of a diabetic patient with sinus and peri-orbital involvement (often presenting as black eschar or rapid tissue necrosis) is highly suggestive of **Mucormycosis** (Zygomycosis). This is a medical emergency. **Amphotericin B** is the drug of choice for Mucormycosis because it has the broadest spectrum of activity against most systemic fungi, including *Mucor* and *Rhizopus* species. It works by binding to ergosterol in the fungal cell membrane, creating pores that lead to cell death. In such invasive cases, **Liposomal Amphotericin B** is preferred due to its lower nephrotoxicity and better CNS/tissue penetration. **Why other options are incorrect:** * **Itraconazole (B):** While effective for dermatophytosis and certain systemic infections like Histoplasmosis, it has **no activity** against Mucormycosis. * **Ketoconazole (C):** This is an older imidazole primarily used topically or for Cushing’s syndrome; it is not indicated for invasive, life-threatening systemic fungal infections. * **Broad-spectrum antibiotics (D):** These target bacteria, not fungi. In fact, their use can sometimes predispose a patient to fungal overgrowth by altering normal flora. **High-Yield Clinical Pearls for NEET-PG:** * **Mucormycosis Triad:** Uncontrolled Diabetes (Ketoacidosis), Rhino-orbital-cerebral involvement, and Broad non-septate hyphae (branching at right angles) on biopsy. * **Amphotericin B Side Effects:** "Shake and Bake" (fever/chills), nephrotoxicity (renal tubular acidosis Type 1), and hypokalemia. * **Newer Alternative:** **Isavuconazole** and **Posaconazole** are the only azoles effective against Mucormycosis and are used as step-down therapy or in patients intolerant to Amphotericin B.

Q: Minocycline causes discoloration of:

Both. **Explanation:** **Minocycline**, a semi-synthetic second-generation Tetracycline, is unique due to its high lipid solubility [2], [3]. Unlike other tetracyclines that primarily affect calcifying tissues during development, minocycline can cause hyperpigmentation in adults across various tissues. 1. **Why "Both" is correct:** * **Teeth:** Minocycline causes intrinsic staining of **fully formed adult teeth**. This occurs via two mechanisms: it binds to plasma proteins that are then deposited in the dentin, and it can also be secreted in saliva, causing extrinsic staining through oxidation. * **Palate:** It frequently causes a characteristic **blue-grey/muddy-brown pigmentation** of the hard palate and oral mucosa. This is due to the deposition of iron-containing pigments or metabolic byproducts in the connective tissue. 2. **Analysis of Options:** * **Option A & B:** While both are true individually, they are incomplete. Minocycline is notorious for affecting both dental structures and mucosal surfaces (palate, gingiva, and tongue). 3. **NEET-PG High-Yield Pearls:** * **Mechanism of Action:** Inhibits protein synthesis by binding to the **30S ribosomal subunit** [3]. * **Tissue Distribution:** Due to high lipid solubility, it achieves high concentrations in **saliva and tears** (useful for treating meningococcal carrier states) [1], [2]. * **Specific Side Effects:** * **Vestibular Toxicity:** Causes vertigo, ataxia, and nausea (unique to minocycline) [1], [4]. * **Skin Pigmentation:** Can cause blue-grey discoloration in scars, shins, and sun-exposed areas. * **Drug-Induced Lupus:** Minocycline is a known trigger for systemic lupus-like syndrome. * **Contraindication:** Like all tetracyclines, it is contraindicated in pregnancy and children under 8 years due to bone growth inhibition and enamel hypoplasia [3].

Question 1

Which among the following antimicrobials exhibits a long post-antibiotic effect?

Accepted Answer

Quinolones

Answer

Macrolides

Answer

Beta-lactams

Answer

Oxazolidinones

Question 2

Which of the following adverse effects of Penicillin is dose-related?

Accepted Answer

Encephalopathy

Answer

Skin rash

Answer

Interstitial Nephritis

Answer

Drug fever

Question 3

Which of the following statements about fluoroquinolones is FALSE?

Accepted Answer

A fluoroquinolone is the drug of choice for treatment of an uncomplicated urinary tract infection in a 7-year-old girl.

Answer

Gonococcal resistance to fluoroquinolones may involve changes in DNA gyrase.

Answer

Modification of fluoroquinolone dosage is required in patients if creatinine clearance is less than 50 mL/min.

Answer

Fluoroquinolones inhibit relaxation of positively supercoiled DNA.

Question 4

The dose of which antibiotic need not be altered in renal failure?

Accepted Answer

Erythromycin

Answer

Vancomycin

Answer

Ethambutol

Answer

Ciprofloxacin

Question 5

Which antifungal agent is also used as a chemotherapeutic agent for cancer?

Accepted Answer

Flucytosine

Answer

Nystatin

Answer

Voriconazole

Answer

Terbinafine

Question 6

Which anti-tubercular drug is not typically given to children under 6 years of age?

Accepted Answer

Ethambutol

Answer

Isoniazid

Answer

Streptomycin

Answer

Rifampicin

Question 7

In a patient with culture-positive enterococcal endocarditis who has failed to respond to vancomycin due to resistance, what is the most likely effective treatment?

Accepted Answer

Linezolid

Answer

Clarithromycin

Answer

Minocycline

Answer

Ticarcillin

Question 8

A 30-year-old female with PCOD, on treatment, presented with complaints of hirsutism. She was given a topical cream that inhibits the ornithine decarboxylase enzyme. Which of the following parasitic infections can be managed with this drug?

Accepted Answer

West African trypanosomiasis

Answer

East African trypanosomiasis

Answer

South American trypanosomiasis

Answer

Visceral leishmaniasis

Question 9

A diabetic patient presents with fungal infection of sinuses and peri-orbital region with significant visual impairment. What is the best drug for treatment of this patient?

Accepted Answer

Amphotericin B

Answer

Itraconazole

Answer

Ketoconazole

Answer

Broad spectrum antibiotics

Question 10

Minocycline causes discoloration of:

Accepted Answer

Both

Answer

Teeth

Answer

Palate

Answer

None

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?